Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Vous n'êtes pas connecté
Two studies published in the latest issue of the journal Cell by University of Pittsburgh researchers in the USA, uncover how immunotherapies targeting the immune checkpoints PD1 and LAG3 work together to activate immune responses. The findings shed light on why combination therapies targeting both checkpoints can improve outcomes for melanoma patients compared to monotherapies targeting [...]
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Advanced treatments, known as immunotherapies that activate T cells—our body's immune cells—to eliminate cancer cells, have shown limited efficacy...
Using real-world data, Mass General Brigham researchers reveal how the combination of two blood cancer medications can improve outcomes for patients...
Using real-world data, Mass General Brigham researchers reveal how the combination of two blood cancer medications can improve outcomes for patients...
Melanoma, one of the deadliest forms of skin cancer, affects an estimated 330,000 people worldwide each year and causes nearly 60,000 deaths...
Melanoma, one of the deadliest forms of skin cancer, affects an estimated 330,000 people worldwide each year and causes nearly 60,000 deaths...
The innate immune system is the body's first line of defense against pathogens and foreign substances. An essential component of this system are...
In a comprehensive Genomic Press Thought Leaders Invited Review, researchers have synthesized findings from dozens of studies examining how genetic...
Researchers identified two genetically distinct brain cell types that help categorize odors, triggering either positive or negative emotional...
An innovative bnano-immune agonist/b has been developed to significantly enhance bimmunotherapy outcomes for medlinkmelanoma/medlink/b, a